121 related articles for article (PubMed ID: 10622325)
1. Genetic enhancement of radionuclide cancer therapy.
Wheldon TE; Mairs RJ; Boyd M
Lancet; 1999 Dec; 354(9194):1999-2000. PubMed ID: 10622325
[No Abstract] [Full Text] [Related]
2. Comparison of radiohaloanalogues of meta-iodobenzylguanidine (MIBG) for a combined gene- and targeted radiotherapy approach to bladder carcinoma.
Fullerton NE; Boyd M; Ross SC; Pimlott SL; Babich J; Kirk D; Zalutsky MR; Mairs RJ
Med Chem; 2005 Nov; 1(6):611-8. PubMed ID: 16787344
[TBL] [Abstract][Full Text] [Related]
3. Combining a targeted radiotherapy and gene therapy approach for adenocarcinoma of prostate.
Fullerton NE; Boyd M; Mairs RJ; Keith WN; Alderwish O; Brown MM; Livingstone A; Kirk D
Prostate Cancer Prostatic Dis; 2004; 7(4):355-63. PubMed ID: 15477875
[TBL] [Abstract][Full Text] [Related]
4. Applications of gene transfer to targeted radiotherapy.
Mairs RJ; Cunningham SH; Boyd M; Carlin S
Curr Pharm Des; 2000 Sep; 6(14):1419-32. PubMed ID: 10903401
[TBL] [Abstract][Full Text] [Related]
5. Potential and pitfalls of therapy with alpha-particles.
Welch MJ
J Nucl Med; 2005 Aug; 46(8):1254-5. PubMed ID: 16085579
[No Abstract] [Full Text] [Related]
6. Noradrenaline transporter gene transfer for radiation cell kill by 131I meta-iodobenzylguanidine.
Boyd M; Cunningham SH; Brown MM; Mairs RJ; Wheldon TE
Gene Ther; 1999 Jun; 6(6):1147-52. PubMed ID: 10455418
[TBL] [Abstract][Full Text] [Related]
7. [131I]MIBG radionuclide therapy in carcinoid syndrome.
Taal BG; Zuetenhorst H; Valdés Olmos RA; Hoefnagel CA
Eur J Surg Oncol; 2002 Apr; 28(3):243. PubMed ID: 11944956
[No Abstract] [Full Text] [Related]
8. Radionuclide Therapies in Molecular Imaging and Precision Medicine.
Kendi AT; Moncayo VM; Nye JA; Galt JR; Halkar R; Schuster DM
PET Clin; 2017 Jan; 12(1):93-103. PubMed ID: 27863570
[TBL] [Abstract][Full Text] [Related]
9. Gene manipulation to enhance MIBG-targeted radionuclide therapy.
Mairs RJ; Fullerton NE; Cosimo E; Boyd M
Nucl Med Biol; 2005 Oct; 32(7):749-53. PubMed ID: 16243651
[TBL] [Abstract][Full Text] [Related]
10. [Nuclear medicine in oncotherapy].
Pávics L; Besenyi Z
Magy Onkol; 2015 Sep; 59(3):193-7. PubMed ID: 26339908
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters.
Glowniak JV; Kilty JE; Amara SG; Hoffman BJ; Turner FE
J Nucl Med; 1993 Jul; 34(7):1140-6. PubMed ID: 8315492
[TBL] [Abstract][Full Text] [Related]
12. New Agents in Clinical Oncology. 24 November 2006, London, UK.
Martin S
IDrugs; 2007 Feb; 10(2):99-101. PubMed ID: 17285459
[No Abstract] [Full Text] [Related]
13. The ARRONAX project.
Haddad F; Barbet J; Chatal JF
Curr Radiopharm; 2011 Jul; 4(3):186-96. PubMed ID: 22201708
[TBL] [Abstract][Full Text] [Related]
14. A transfectant mosaic xenograft model for evaluation of targeted radiotherapy in combination with gene therapy in vivo.
Mairs RJ; Ross SC; McCluskey AG; Boyd M
J Nucl Med; 2007 Sep; 48(9):1519-26. PubMed ID: 17704246
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic nuclear medicine in pediatric malignancy.
Schmidt M; Baum RP; Simon T; Howman-Giles R
Q J Nucl Med Mol Imaging; 2010 Aug; 54(4):411-28. PubMed ID: 20823809
[TBL] [Abstract][Full Text] [Related]
16. Specific binding and uptake of 131I-MIBG and 111In-octreotide in metastatic paraganglioma--tools for choice of radionuclide therapy.
Spetz J; Dalmo J; Nilsson O; Wängberg B; Ahlman H; Forssell-Aronsson E
Horm Metab Res; 2012 May; 44(5):400-4. PubMed ID: 22566195
[TBL] [Abstract][Full Text] [Related]
17. Iodopyridine-for-iodobenzene substitution for use with low molecular weight radiopharmaceuticals: application to m-iodobenzylguanidine.
Vaidyanathan G; Zalutsky MR; DeGrado TR
Bioconjug Chem; 1998; 9(6):758-64. PubMed ID: 9815170
[TBL] [Abstract][Full Text] [Related]
18. Expression in UVW glioma cells of the noradrenaline transporter gene, driven by the telomerase RNA promoter, induces active uptake of [131I]MIBG and clonogenic cell kill.
Boyd M; Mairs RJ; Mairs SC; Wilson L; Livingstone A; Cunningham SH; Brown MM; Quigg M; Keith WN
Oncogene; 2001 Nov; 20(53):7804-8. PubMed ID: 11753659
[TBL] [Abstract][Full Text] [Related]
19. [Radio iodized metaiodobenzylguanidine (MIBG) in the treatment of neuroblastoma: modalities and indications].
Défachelles AS; Cougnenc O; Carpentier P
Bull Cancer; 2011 May; 98(5):559-69. PubMed ID: 21609890
[TBL] [Abstract][Full Text] [Related]
20. Progress in Targeted Alpha-Particle Therapy. What We Learned about Recoils Release from In Vivo Generators.
Kozempel J; Mokhodoeva O; Vlk M
Molecules; 2018 Mar; 23(3):. PubMed ID: 29510568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]